Service de Médecine intensive et réanimation, Centre Hospitalier Universitaire Gabriel Montpied, Clermont-Ferrand, France.
Service de Soins intensifs adultes, Hôpitaux Universitaires de Genève, Geneva, Switzerland.
PLoS One. 2020 Dec 14;15(12):e0243762. doi: 10.1371/journal.pone.0243762. eCollection 2020.
Multiplex polymerase chain reaction (mPCR) for respiratory virus testing is increasingly used in community-acquired pneumonia (CAP), however data on one-year outcome in intensive care unit (ICU) patients with reference to the causative pathogen are scarce.
We performed a single-center retrospective study in 123 ICU patients who had undergone respiratory virus testing for CAP by mPCR and with known one-year survival status. Functional status including dyspnea (mMRC score), autonomy (ADL Katz score) and need for new home-care ventilatory support was assessed at a one-year post-ICU follow-up. Mortality rates and functional status were compared in patients with CAP of a bacterial, viral or unidentified etiology one year after ICU admission.
The bacterial, viral and unidentified groups included 19 (15.4%), 37 (30.1%), and 67 (54.5%) patients, respectively. In multivariate analysis, one-year mortality in the bacterial group was higher compared to the viral group (HR 2.92, 95% CI 1.71-7.28, p = 0.02) and tended to be higher compared to the unidentified etiology group (p = 0.06); but no difference was found between the viral and the unidentified etiology group (p = 0.43). In 64/83 one-year survivors with a post-ICU follow-up consultation, there were no differences in mMRC score, ADL Katz score and new home-care ventilatory support between the groups (p = 0.52, p = 0.37, p = 0.24, respectively). Severe dyspnea (mMRC score = 4 or death), severe autonomy deficiencies (ADL Katz score ≤ 2 or death), and major adverse respiratory events (new home-care ventilatory support or death) were observed in 52/104 (50.0%), 47/104 (45.2%), and 65/104 (62.5%) patients, respectively; with no difference between the bacterial, viral and unidentified group: p = 0.58, p = 0.06, p = 0.61, respectively.
CAP of bacterial origin had a poorer outcome than CAP of viral or unidentified origin. At one-year, impairment of functional status was frequently observed, with no difference according to the etiology.
多重聚合酶链反应(mPCR)在社区获得性肺炎(CAP)的呼吸道病毒检测中应用越来越广泛,但有关重症监护病房(ICU)患者病因相关病原体的一年后结局数据却很少。
我们对 123 例在 ICU 进行了 mPCR 检测以明确 CAP 病因的患者进行了单中心回顾性研究,这些患者的一年后生存状况已知。在 ICU 后一年的随访中,通过 mMRC 呼吸困难评分、ADL Katz 评分和新家庭呼吸支持的需求来评估患者的功能状态。比较 CAP 为细菌性、病毒性或不明原因病因患者在 ICU 入院一年后的死亡率和功能状态。
细菌性、病毒性和不明原因组分别包括 19 例(15.4%)、37 例(30.1%)和 67 例(54.5%)患者。多变量分析显示,与病毒性组相比,细菌性组的一年死亡率更高(HR 2.92,95%CI 1.71-7.28,p = 0.02),且与不明原因组相比有更高的趋势(p = 0.06);但病毒性组与不明原因组之间无差异(p = 0.43)。在 83 例进行 ICU 后随访的一年幸存者中,三组间 mMRC 评分、ADL Katz 评分和新家庭呼吸支持无差异(p = 0.52,p = 0.37,p = 0.24)。在 104 例中有 mMRC 评分=4 分或死亡、ADL Katz 评分≤2 分或死亡、主要不良呼吸事件(新家庭呼吸支持或死亡)的患者中,分别为 52/104(50.0%)、47/104(45.2%)和 65/104(62.5%),三组间无差异:p = 0.58,p = 0.06,p = 0.61。
细菌性 CAP 的结局较病毒性或不明原因性 CAP 差。在一年时,功能状态受损较为常见,但与病因无关。